Hospital-Acquired Infection Control Market Projected to Gain Significant Value through 2033

According to the recently released Hospital-acquired Infection Control Market analysis report by Future Market Insights, worldwide Hospital-acquired Infection Control sales in 2023 are anticipated to be US$ 6.5 billion. The market is estimated to reach $12.7 billion by 2033, growing at a CAGR of 7% between 2023 and 2033. With a CAGR of 7.6%, hospitals and intensive care units are expected to generate significant revenue in the industry.

The occurrence of hospital-acquired infections, the increasing proportion of surgical procedures, the growing geriatric population and the increasing prevalence of chronic diseases, technological advancements in sterilisation equipment, and growing awareness of environmental and personal hygiene are the key factors driving the Hospital-acquired infection control market.

The growing use of e-beam sterilisation and the reintroduction of ethylene oxide sterilisation are expected to drive up demand for hospital-acquired infection management.

The percentage of procedures performed worldwide has increased dramatically throughout the years. According to the WHO, around 235 million complex surgical procedures are performed globally each year. This is due to an increase in obesity and other lifestyle problems, an increase in the senior population, and an increase in spine injuries and sports-related injuries.

The demand for diverse surgical equipment and medical gadgets grows in tandem with the number of surgical procedures performed. The proven benefits of sterile product lines, as well as improved knowledge of their efficacy in healthcare settings, are expected to boost demand for hospital-acquired infection services.

The Asia Pacific market is estimated to rise at a CAGR of more than 7% during the forecast period, owing to rising demand for Hospital-acquired Infection Control strategies in developing countries, particularly Japan.

As a result of the broad use of hospital-acquired infection controls and increased working-class awareness of general health and fitness, the regional market is expanding.

Competitive Analysis

The key players in the market include Steris Plc, Sotera Health Company, Getinge AB, Advanced Sterilization Products, Ecolab Inc., 3M Company, Matachana Group, MMM Group, Belimed AG, and Reckitt Benckiser.

Get More Details About Report@ https://www.futuremarketinsights.com/reports/hospital-acquired-infection-control-market

Market Segments Covered in Hospital-acquired Infection Control Industry Analysis
By Component:

  • Equipment
  • Sterilization Equipment
  • Disinfection Equipment
  • Consumables
  • Disinfectants
  • Sterilization Consumables
  • Others (Waste Disposal, PPE)
  • Services

By End-user:

  • Hospitals and Intensive Care Units
  • Ambulatory Surgical and Diagnostic Centers
  • Other End-users

Comments

Post a Comment

Popular posts from this blog

Targeted Therapies for Sandhoff Disease | Assessing the Global Market Landscape

Image
The global Sandhoff Disease Therapeutics Market Size is expected to be worth US$ 10 million in 2023 and US$ 17.91 million by 2033, with a CAGR of 6% from 2023 to 2033. From 2018 to 2022, the Sandhoff Disease Treatments market increased at a 4% CAGR. According to the most recent studies, Sandhoff sickness is a rare disorder that affects 1 in 1,000,000 people. The rising demand for these medications is projected to spur the discovery of novel therapies, propelling the market forward in the coming years. Gene therapy is being investigated as a potential treatment for Sandhoff disease. The therapy restores the ability to break down GM2 ganglioside by delivering a functional copy of the missing enzyme into the patient's cells. This has the potential to reduce or stop disease progression while also improving patient quality of life. Key Takeaways from the Market Study   The Sandhoff Disease Therapeutics market increased at a 4% CAGR from 2018 to 2022. From 2023 to 2033, the global Sandh
Read more

A Safer Tomorrow | Emerging Trends in Hospital-Acquired Infection Control Market

Image
According to Future Market Insights' recently released Hospital-acquired Infection Control Market analysis report, global Hospital-acquired Infection Control sales in 2023 are expected to be US$ 6.5 billion. The market is expected to increase at a CAGR of 7% between 2023 and 2033, reaching $12.7 billion by 2033. Hospitals and intensive care units are predicted to create significant income in the market, with a CAGR of 7.6%. The occurrence of hospital-acquired infections, increasing proportion of surgical procedures, growing geriatric population and increasing prevalence of chronic diseases, technological advancements in sterilisation equipment, and growing awareness of environmental and personal hygiene are the key factors driving the Hospital-acquired infection control market. The increased use of e-beam sterilisation, as well as the reintroduction of ethylene oxide sterilisation, is predicted to increase demand for hospital-acquired infection management. The percentage of treatm
Read more

Transforming Trauma | Emerging Therapies and Interventions in Post-Traumatic Stress Disorder Treatment Market

Image
According to Future Market Insights, the Post-Traumatic Stress Disorder (PTSD) Treatment Market Sales would grow at a 5% CAGR between 2023 and 2033. By 2033, the global market for post-traumatic stress disorder (PTSD) therapy is expected to reach US$ 27.37 billion. The market's growth might be attributed to the increased prevalence of PTSD globally. According to the National Centre for PTSD, approximately 7-8% of the US population will develop PTSD at some point in their lives, with greater percentages among military veterans and persons who have experienced sexual assault or other types of trauma. The COVID-19 pandemic has also been highlighted as a possible cause of PTSD, with healthcare workers, first responders, and people immediately impacted by the virus being especially vulnerable. In addition, there is a growing emphasis on using digital therapies and other non-pharmacological techniques to treat PTSD. For example, virtual reality exposure treatment (VRET) has shown potent
Read more